Conjugate vaccine against group b streptococcus

Details Conjugate vaccine against group b streptococcus Conjugate vaccine against group b streptococcus

C - Chemistry, Metallurgy

12

N

C12N 15/31 (2006.01) A61K 39/09 (2006.01) A61K 47/48 (2006.01) C07K 14/315 (2006.01) C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 15/70 (2006.01)

Patent

CA 2146926

A vaccine capable of protecting a recipient from infection caused by group B Streptococcus. The vaccine provides polysac- charide-protein moieties and contain (a) a group B Streptococcus polysaccharide conjugated to (b) a functional derivative of a group B Streptococcus C protein alpha antigen that retains the ability to elicit protective antibodies against group B Streptococcus. The vaccine may contain only one type of such polysaccharide-protein unit or may contain a mixture of more than one type of un- it.

Affiliated with

Also associated with

Rating

Conjugate vaccine against group b streptococcus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Conjugate vaccine against group b streptococcus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Conjugate vaccine against group b streptococcus will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1350606